Back
Staar Surgical Vs. Neurocrine Biosciences Industry Stock Comparison
Buy
73
STAA
Staar Surgical
Last Price:
46.73
Seasonality Move:
13.21%
Buy
69
NBIX
Neurocrine Biosciences
Last Price:
137.01
Seasonality Move:
8.2%
Buy
73
Staar Surgical (STAA)
is a Buy
Is Staar Surgical a Buy, Sell or Hold?
- The current Staar Surgical [STAA] share price is $47.82. The Score for STAA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- STAA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $138.97. The Score for NBIX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STAA Stock Price Chart
What is Staar Surgical's stock price today?
-
The Staar Surgical share price today is $47.82
The current trend is moderately bullish and STAA is experiencing selling pressure, which indicates risk of future bearish movement.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $138.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
STAA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.52 | Buy |
| Relative Strength Index (14 RSI): | 62.08 | Buy |
| Chaikin Money Flow: | -522871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.02 - 49.44) | Buy |
| Bollinger Bands (100): | (28.62 - 41.36) | Buy |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 55.63 | Buy |
| Chaikin Money Flow: | -628864 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.26 - 140.84) | Buy |
| Bollinger Bands (100): | (126.47 - 140.67) | Buy |
STAA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.86 | Buy |
| 20-day SMA: | 45.85 | Buy |
| 50-day SMA: | 39.03 | Buy |
| 200-day SMA: | 38.91 | Buy |
| 8-day EMA: | 47.33 | Buy |
| 20-day EMA: | 45.51 | Buy |
| 50-day EMA: | 40.95 | Buy |
| 200-day EMA: | 41.34 | Buy |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.44 | Buy |
| 20-day SMA: | 136.57 | Buy |
| 50-day SMA: | 136.4 | Buy |
| 200-day SMA: | 121 | Buy |
| 8-day EMA: | 136.08 | Buy |
| 20-day EMA: | 136.36 | Buy |
| 50-day EMA: | 135.96 | Buy |
| 200-day EMA: | 124.3 | Buy |
Staar Surgical Earnings Growth & STAA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.42 per share, and an increase next year of $0.39 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.89 per share, and an increase next year of $1.77 per share.
Staar Surgical Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||